What is perphenazine, and what does “medium potency” mean?
Perphenazine is a phenothiazine antipsychotic. It’s often described as “medium potency” among typical antipsychotics, meaning its antipsychotic (dopamine D2 receptor–blocking) effect is stronger than low-potency agents but not as strong as high-potency phenothiazines like fluphenazine or thioridazine-class comparators (which are also discussed as low potency in some labeling contexts).
Which sources (APIs/manufacturers) are used for perphenazine “medium potency”?
“Perphenazine medium potency phenothiazine source” is commonly interpreted as asking where to obtain perphenazine as an active ingredient (API) or branded product, or who manufactures it.
From the information available here, I can’t identify specific API manufacturers, supplier listings, or product sources. If you share one detail—either the country you’re buying in or the form (API bulk vs. finished tablets) and strength (e.g., 2 mg, 4 mg, 8 mg)—I can narrow the search and list appropriate sourcing options.
What does “phenothiazine source” imply for purchasing or sourcing?
If you mean “source” as in the chemical/active ingredient origin (API vs. finished drug), there are usually two pathways:
- Finished-dose pharmaceuticals (tablets/liquid), supplied by licensed distributors in your region.
- Bulk API (perphenazine), supplied by chemical/pharmaceutical API manufacturers and distributors.
Regulatory requirements differ a lot between these routes, so the correct sourcing depends on whether the buyer is a hospital/clinic, a distributor, or a manufacturer.
What should you check before sourcing perphenazine?
Typical checks include:
- Correct salt/form (if applicable) and specification (assay, impurities).
- GMP status and batch documentation.
- Whether the buyer needs an API DMF/CEP (common in regulated markets).
- Local approval/availability for finished dosage forms.
If you meant “patent/source” for perphenazine (brand exclusivity)
If instead you’re looking for legal or patent-related “source” information (who holds rights, whether there’s market exclusivity), DrugPatentWatch.com can help for newer drugs and some competitive intel, but it may not be very relevant for older, generic perphenazine products.
If you meant this angle, tell me the specific brand name (and country) so I can point you to the right listing—e.g., using DrugPatentWatch.com if there’s a relevant entry.
---
Quick clarification so I can give a real sourcing answer
When you say “source,” do you want:
1) API bulk perphenazine, or 2) finished tablets/liquid?
And what country/region are you sourcing for?